Current and emerging biomarkers for melanoma care | 33 min 1

Biomarkers are revolutionising our understanding of melanoma by providing valuable information about a patient's unique tumour characteristics which can help guide clinical decision making.

In this podcast, A/Prof Alex Menzies leads a multidisciplinary discussion on the current state of biomarker application and future prospects of biomarkers in melanoma care. They discuss emerging liquid biomarkers, such as ctDNA, MIA’s personalised immunotherapy platform that is trying to predict the likelihood of response and select patients for treatment, and the role of the gut microbiome as a potential biomarker in response and toxicity.

This podcast is suitable for Medical Oncologists, Surgical Oncologists, Researchers, GPs and other healthcare professionals.

Subscribe to our Melanoma Insights for Professionals podcasts via iTunes or Spotify or your favourite podcast app.


SPEAKERS
A/Prof Alexander Menzies
Medical Oncologist, Melanoma Institute Australia and Royal North Shore and Mater Hospitals | Associate Professor of Melanoma Medical Oncology, The University of Sydney
Declaration of Interest




A/Prof Ines Silva
Medical Oncologist, Melanoma Institute Australia and Blacktown Hospital | Research Scientist, Melanoma Institute Australia and The University of Sydney

Declaration of Interest


Prof Helen Rizos
Cancer Cell Biologist and Research Lead in the Faculty of Medicine, Health and Human Sciences at Macquarie University | Faculty Member, Melanoma Institute Australia
Declaration of Interest



A/Prof James Wilmott
Senior Scientist, Charles Perkins Centre, The University of Sydney| Faculty Member, Melanoma Institute Australia




HOST
Danielle Fischer
Education Program Manager, Melanoma Institute Australia
Declaration of Interest




Please note that this podcast was accurate at the time of recording (April 2024) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

  

• Module1.1
  Current and emerging biomarkers for melanoma care | 33 min
  41 min